Whereas low DICER1 expression has been correlated with worse prognosis in chronic lymphocytic leukemia and melanoma [46, 47], high expression has been correlated with reduced survival in prostate adenocarcinomas and colorectal carcinomas [48, 49]. Here, DICER1 is linked to melanoma.